Biotech Stock 685% Draws Big Investment Amid FDA Filings
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
The debate between points and cash back is ongoing. Understand the benefits of each to determine which suits you best.
28,655 articlesA biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
The federal debt breached $39 trillion this week as lawmakers debated a constitutional fix that failed to pass. The p...
SpaceX IPO chatter has investors buzzing about windfalls for insiders and thousands of workers with equity. This repo...
New data confirms Baby Boomers own the majority of U.S. household wealth, fueling debate about intergenerational powe...
The U.S. spent billions to replace textbooks with laptops and tablets in classrooms, but new data show cognitive gain...
The Federal Reserve will solicit public feedback on broadening master account access to more crypto and fintech firms...
A new AI coaching platform is launching to give every loan officer a personalized, on-demand coach. Early pilots show...
A Honeywell-backed trapped-ion quantum company began trading on NASDAQ, priced around $60 a share and signaling that ...
Gen Z is slowing the pace of career jumps in favor of skill-building and strategic planning, a trend that could redef...
CrowdStrike is moving to a 4-for-1 stock split. This guide breaks down what the split does, how it affects you as an ...
Advanced Micro Devices stock rallied more than 8% on a Wednesday as software gains lifted the tech sector. Learn what...
When high-level insiders transact, it sparks questions. This article explains what medical's general counsel sells si...